News - Galvus

Filter

Current filters:

Galvus

Popular Filters

Positive new data on Novartis' Galvus in elderly type 2 diabetes patients

23-05-2013

Results of the INTERVAL study were published on line in The Lancet today (May 23) and for the first time…

DiabetesGalvusNovartisPharmaceuticalResearch

Drug approval and launch for Novartis in China, where Quintiles expands

18-01-2012

Swiss drug major Novartis (NOVN: VX) says it has received regulatory approval in China from the State…

Asia-PacificDiabetesGalvusLucentisMarkets & MarketingNovartisOphthalmicsPharmaceuticalQuintilesRegulationResearch

Diabetes Rxing in China and S Korea

07-12-2011

Dipeptidyl peptidase IV (DPP-IV) inhibitors are prescribed more commonly for the treatment of type 2…

Asia-PacificDiabetesGalvusJanuviaMarkets & MarketingMerck & CoNovartisPharmaceuticalPricing

EU approval for added use of Novartis diabetes drug Galvus

06-12-2011

The European Commission has approved Swiss drug major Novartis’ (NOVN: VX) Galvus (vildagliptin)…

DiabetesEuropeGalvusNovartisPharmaceuticalRegulation

Back to top